Russia Begins supply of "Afavavir" approved for new corona drug June 12, 21:13
In Russia, where the new coronavirus infection continues to spread, the supply of the therapeutic drug “Afavavir”, which was approved last month, has started.
Avifavir has been developed by medical universities in Russia, etc., and it was approved as a new coronavirus treatment for the first time in Russia on the 29th of last month as "the safety was confirmed as a result of clinical trials". .
On the 11th, the government-affiliated fund "Russian Direct Investment Fund" that led the development announced that it has started to supply "Avifavir" free of charge to hospitals and other locations in Russia.
On top of that, we have indicated that we will expand our production capacity in the future and consider exporting if there is a request from a foreign government.
Russia has more than 500,000 new-type coronavirus infections, the third largest in the world after the United States and Brazil, and more than 8,000 new infections per day are still being confirmed.
It seems that the Russian government aims to ease the anxiety of the people by appealing the development of new therapeutic agents.